Brigham Young University scientists say their MOTO‑CAR platform cut aggressive lung cancer cells by 90% in lab tests, highlighting a potential low‑cost immunotherapy route.
Brigham Young University scientists say their MOTO‑CAR platform cut aggressive lung cancer cells by 90% in lab tests, highlighting a potential low‑cost immunotherapy route.